Atlas Trials

A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice

Clinical trial NCT07284121 · RECRUITING

Trial details

NCT number
NCT07284121
Sponsor
Hoffmann-La Roche
Status
RECRUITING
Study type
OBSERVATIONAL
Lung Cancer, Hepatocellular Carcinoma
Start date
2025-07-15
Primary completion
2027-03-31
Enrollment
700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.